When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and